• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Solubilized rabbit striatal A2a-adenosine receptors: stability and antagonist binding.可溶性兔纹状体A2a - 腺苷受体:稳定性与拮抗剂结合
Arch Biochem Biophys. 1993 Sep;305(2):611-7. doi: 10.1006/abbi.1993.1469.
2
Characterization of human striatal A2-adenosine receptors using radioligand binding and photoaffinity labeling.利用放射性配体结合和光亲和标记对人纹状体A2-腺苷受体进行表征。
J Recept Res. 1992;12(2):149-69. doi: 10.3109/10799899209074789.
3
Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes.放射性配体[3H]-SCH 58261(一种新型非黄嘌呤类A2A腺苷受体拮抗剂)与大鼠纹状体膜的结合。
Br J Pharmacol. 1996 Apr;117(7):1381-6. doi: 10.1111/j.1476-5381.1996.tb15296.x.
4
Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.大鼠海马体和大脑皮层中存在与纹状体A2A受体不同的腺苷A2A受体激动剂[3H] CGS 21680的高亲和力结合位点的证据。
Naunyn Schmiedebergs Arch Pharmacol. 1996 Feb;353(3):261-71. doi: 10.1007/BF00168627.
5
A1 adenosine receptor-G protein coupling in bovine brain membranes: effects of guanine nucleotides, salt, and solubilization.牛脑膜中A1腺苷受体与G蛋白的偶联:鸟嘌呤核苷酸、盐和增溶作用的影响。
J Neurochem. 1988 Nov;51(5):1592-8. doi: 10.1111/j.1471-4159.1988.tb01129.x.
6
Reciprocal modulation of agonist and antagonist binding to A1 adenosine receptors by guanine nucleotides is mediated via a pertussis toxin-sensitive G protein.鸟嘌呤核苷酸对激动剂和拮抗剂与A1腺苷受体结合的相互调节是通过一种百日咳毒素敏感的G蛋白介导的。
J Pharmacol Exp Ther. 1988 Sep;246(3):1194-200.
7
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.纹状体A2a腺苷受体的化学修饰与不可逆抑制
Mol Pharmacol. 1992 Jul;42(1):123-33.
8
A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.豚鼠大脑皮层中A1腺苷受体对环磷酸腺苷形成及放射性配体结合的抑制作用。
Br J Pharmacol. 1994 Dec;113(4):1501-7. doi: 10.1111/j.1476-5381.1994.tb17166.x.
9
Demonstration of both A1 and A2 adenosine receptors in DDT1 MF-2 smooth muscle cells.DDT1 MF-2平滑肌细胞中A1和A2腺苷受体的证实。
Mol Pharmacol. 1990 Feb;37(2):149-56.
10
Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.用拮抗剂放射性配体[3H]-SCH 58261对人A2A腺苷受体进行表征。
Br J Pharmacol. 1997 Jun;121(3):353-60. doi: 10.1038/sj.bjp.0701119.

引用本文的文献

1
Co-evolving stability and conformational homogeneity of the human adenosine A2a receptor.人腺苷A2a受体共同进化的稳定性和构象均一性。
Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10744-9. doi: 10.1073/pnas.0804396105. Epub 2008 Jul 29.

本文引用的文献

1
2-[2-[4-[2-[2-[ 1,3-Dihydro- 1,1-bis (4-hydroxyphenyl)-3-oxo-5-isobenzofuranthioureidyl]ethylaminocarbonyl]ethyl]phenyl] ethylamino]-5'--ethylcarboxamidoadenosine (FITC-APEC): A Fluorescent Ligand For A-Adenosine Receptors.2-[2-[4-[2-[2-[1,3-二氢-1,1-双(4-羟基苯基)-3-氧代-5-异苯并呋喃硫脲基]乙氨基甲酰基]乙基]苯基]乙氨基]-5'-乙基羧酰胺腺苷(FITC-APEC):一种α-腺苷受体的荧光配体。
J Fluoresc. 1992 Dec;2(4):217-223. doi: 10.1007/BF00865279.
2
[(3)H]XAC (xanthine amine congener) is a radioligand for A(2)-adenosine receptors in rabbit striatum.[(3)H]XAC(黄嘌呤胺类似物)是兔纹状体中A(2)-腺苷受体的放射性配体。
Neurochem Int. 1991;18(2):207-13. doi: 10.1016/0197-0186(91)90187-i.
3
Solubilization and characterization of the A2-adenosine receptor.
J Recept Res. 1993;13(6):961-73. doi: 10.3109/10799899309073703.
4
Solubilization of brain muscarinic, dopaminergic and serotonergic receptors: a critical analysis.脑毒蕈碱能、多巴胺能和5-羟色胺能受体的增溶作用:批判性分析
Biochem Pharmacol. 1982 Jun 15;31(12):2145-51. doi: 10.1016/0006-2952(82)90507-x.
5
Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines.中枢神经系统中腺苷受体的亚类:与咖啡因及相关甲基黄嘌呤的相互作用。
Cell Mol Neurobiol. 1983 Mar;3(1):69-80. doi: 10.1007/BF00734999.
6
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.抑制常数(K1)与导致酶促反应50%抑制率(I50)的抑制剂浓度之间的关系。
Biochem Pharmacol. 1973 Dec 1;22(23):3099-108. doi: 10.1016/0006-2952(73)90196-2.
7
PD 115,199: an antagonist ligand for adenosine A2 receptors.PD 115,199:一种腺苷A2受体的拮抗剂配体。
Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):64-9. doi: 10.1007/BF00165038.
8
Autoradiographic localization of mouse brain adenosine receptors with an antagonist ([3H]xanthine amine congener) ligand probe.用拮抗剂([3H]黄嘌呤胺类似物)配体探针进行小鼠脑腺苷受体的放射自显影定位。
Neurosci Lett. 1988 Mar 31;86(2):121-6. doi: 10.1016/0304-3940(88)90557-5.
9
A [3H]amine congener of 1,3-dipropyl-8-phenylxanthine. A new radioligand for A2 adenosine receptors of human platelets.1,3 - 二丙基 - 8 - 苯基黄嘌呤的一种[3H]胺类似物。一种用于人血小板A2腺苷受体的新型放射性配体。
FEBS Lett. 1986 Apr 21;199(2):269-74. doi: 10.1016/0014-5793(86)80493-8.
10
Solubilization of stable adenosine A1 receptors from rat brain.大鼠脑中稳定腺苷A1受体的增溶作用。
Biochem J. 1989 Jan 15;257(2):413-8. doi: 10.1042/bj2570413.

可溶性兔纹状体A2a - 腺苷受体:稳定性与拮抗剂结合

Solubilized rabbit striatal A2a-adenosine receptors: stability and antagonist binding.

作者信息

Ji X D, Jacobson K A

机构信息

Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

Arch Biochem Biophys. 1993 Sep;305(2):611-7. doi: 10.1006/abbi.1993.1469.

DOI:10.1006/abbi.1993.1469
PMID:8373201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4827164/
Abstract

The A2a-adenosine binding subunit from rabbit striatal membranes was solubilized using 1% 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate and was characterized using the antagonist radioligand [3H]8-[4-[[[[2-aminoethyl)amino]carbonyl]methyl]oxy] phenyl]-1,3-dipropylxanthine (XAC). The solubilized receptor was very stable, with 55% of the specific [3H]XAC binding remaining after storage for 15 days at 4 degrees C. The dissociation constant (Kd) for binding of [3H]XAC to solubilized A2 receptors was determined in saturation studies to be 4.0 nM, with a Bmax of 600 fmol/mg protein. Xanthine inhibitors displaced the specific binding of the adenosine antagonist [3H]XAC (in the presence of 50 nM 8-cyclopentyl-1,3-dipropylxanthine) at 25 degrees C, with Ki values consonant with the expected affinities at A2a receptors. Binding of [3H]XAC (1 nM) or the adenosine agonist [3H]2-(carboxyethylphenylethylamino)adenosine-5'-N-ethyl carboxamide (5 nM) to A2a receptors was diminished in the presence of 0.1 M Na+ in both membranes and solubilized preparations. Agonist binding was increased (by 280% for membranes and 180% for solubilized receptors), and antagonist binding was decreased in the presence of 10 mM Mg2+. Displacement of [3H]XAC by the agonist (R)-N6-phenylisopropyladenosine was biphasic, corresponding to high (IC50 = 188 nM, RH = 30%) and low (IC50 = 9730 nM, RL = 70%) affinity sites. Preincubation with 100 microM GTP (10 mM Mg2+) converted the high affinity binding to low affinity, suggesting that receptor and G-protein are dissociated by the guanine nucleotide. The solubilized receptor was more easily inactivated by exposure to the reducing agent dithiothreitol (IC50 = 3 mM) than in membranes (IC50 = 220 mM), suggesting increased accessibility of structurally essential disulfide bridges.

摘要

使用1%的3-[(3-胆酰胺丙基)二甲基铵]-1-丙烷磺酸盐溶解来自兔纹状体膜的A2a-腺苷结合亚基,并使用拮抗剂放射性配体[3H]8-[4-[[[[2-氨基乙基)氨基]羰基]甲基]氧基]苯基]-1,3-二丙基黄嘌呤(XAC)对其进行表征。溶解的受体非常稳定,在4℃储存15天后,仍有55%的特异性[3H]XAC结合。在饱和研究中,[3H]XAC与溶解的A2受体结合的解离常数(Kd)为4.0 nM,Bmax为600 fmol/mg蛋白质。在25℃下,黄嘌呤抑制剂取代了腺苷拮抗剂[3H]XAC的特异性结合(在50 nM 8-环戊基-1,3-二丙基黄嘌呤存在下),其Ki值与A2a受体的预期亲和力一致。在膜和溶解制剂中,0.1 M Na+存在时,[3H]XAC(1 nM)或腺苷激动剂[3H]2-(羧乙基苯乙氨基)腺苷-5'-N-乙基羧酰胺(5 nM)与A2a受体的结合减少。在10 mM Mg2+存在下,激动剂结合增加(膜增加280%,溶解受体增加180%),拮抗剂结合减少。激动剂(R)-N6-苯异丙基腺苷对[3H]XAC的取代是双相的,对应于高(IC50 = 188 nM,RH = 30%)和低(IC50 = 9730 nM,RL = 70%)亲和力位点。与100 microM GTP(10 mM Mg2+)预孵育将高亲和力结合转化为低亲和力,表明鸟嘌呤核苷酸使受体和G蛋白解离。与膜(IC50 = 220 mM)相比,溶解的受体更容易因暴露于还原剂二硫苏糖醇(IC50 = 3 mM)而失活,这表明结构必需的二硫键的可及性增加。